Uppsala, Sweden

Paraskevi Heldin

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paraskevi Heldin: Innovator in Flavivirus Treatment

Introduction

Paraskevi Heldin is a notable inventor based in Uppsala, Sweden. She has made significant contributions to the field of medical science, particularly in the treatment of viral infections. Her innovative approach has led to the development of a unique method for treating subjects suffering from flavivirus infections.

Latest Patents

Paraskevi Heldin holds 1 patent for her invention titled "Method for treating subject suffering from flavivirus infection." This patent discloses a method that includes administering a pharmaceutical composition containing a pharmaceutically effective amount of an anti-CD44 antibody to the subject. This groundbreaking method aims to provide a new avenue for treating flavivirus infections, which can have serious health implications.

Career Highlights

Paraskevi is affiliated with Kaohsiung Medical University, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical treatments and improving patient outcomes. She has established herself as a key figure in her field, contributing valuable insights and innovations.

Collaborations

Throughout her career, Paraskevi has collaborated with esteemed colleagues, including Yen-Hsu Chen and Chun-Yu Lin. These partnerships have fostered a collaborative environment that enhances the research and development of new medical treatments.

Conclusion

Paraskevi Heldin's contributions to the field of flavivirus treatment exemplify her dedication to medical innovation. Her patent and ongoing research efforts highlight the importance of developing effective therapies for viral infections. Her work continues to inspire advancements in medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…